Search

An interactive web cartoon titled 'Welcome to the Radiology Center' teaches sick children what to expect before undergoing an MR, CT, or chest x-ray study. It also gives them a [...]

The FDA in February allowed Biogen Idec to resume using natalizumab (Tysabri) in clinical trials for patients with relapsing-remitting multiple sclerosis (MS). If the FDA follows the recommendation of its [...]

When Medicare enrollees became entitled to the first-ever outpatient prescription drug benefit in January, the program was introduced with great fanfare and with the mission of Medicare Part D programs [...]

Byline: Laura Newman, MA The most comprehensive evidence-based recommendations for preventing a second stroke have been released by the American Heart Association and the American Stroke Association's Stroke Council.1 In [...]

Alzheimer disease (AD) is less likely to develop in people with a higher education level, but when it does develop, decline is much more rapid, according to a prospective population-based [...]

Byline: Laura Newman, MA The original 2001 McDonald Diagnostic Criteria-a mainstay for diagnosing multiple sclerosis (MS)-have been modified by an international consensus panel. The panel, chaired by Chris H. Polman, [...]

Danes with multiple sclerosis (MS) have a 2-fold higher risk of suicide than the general population, according to a study based on linkage of the Danish Multiple Sclerosis Registry to [...]

Upper-limb pain and repetitive stress injuries occur in more than half the wheelchair-bound population. Biomechanical engineers have been working to reduce these injuries by designing wheelchairs that reduce the peak [...]

Disease-modifying agents have been the mainstay of treatment for relapsing-remitting multiple sclerosis (RRMS) since the National Multiple Sclerosis Society Consensus Statement1 that recommended use of disease-modifying drugs was released in [...]

Byline: Laura Newman A study published in the latest issue of Current Directions in Psychological Science concluded that older adults with mild to moderate hearing loss muster a substantial amount [...]

Byline: Laura Newman, MA Managing cancer pain and end-of-life care has traditionally been the bailiwick of oncologists, nurses, and anesthesiologists. Except for rare instances, neurologists have not been leaders in [...]

Byline: Laura Newman 'Chemobrain,' a term coined by patients in breast cancer support groups to describe cognitive impairment associated with chemotherapy, is becoming a subject of research. 'Chemobrain is not [...]

Byline: Laura Newman, MA In June 2004, New York State's Attorney General Eliot Spitzer filed a lawsuit charging that GlaxoSmithKline PLC committed fraud by withholding negative information and misrepresenting data [...]

Reviewed by Nada S. Jabbur, MD Baltimore -- Use caution when re-treating a patient who has had refractive surgery, advised Nada S. Jabbur, MD. Just as care should be taken [...]

Reviewed by Nathan G. Congdon, MD, MPH Baltimore -- Treatment of people with ocular hypertension without a diagnosis of glaucoma has been poorly understood, but there is no doubt that [...]

Reviewed by Shannath L. Merbs, MD, PhD Baltimore -- Ophthalmologists can be comfortable identifying and managing certain eyelid lesions in their offices if they pay attention to a few basic [...]

Reviewed by John T. Thompson, MD Baltimore -- Using aggressive lobbying techniques and grassroots organizing, optometrists in certain regions of the country have succeeded in getting legislation passed and introducing [...]

Reviewed by Jennifer Sung, MD Baltimore -- Researchers are working to improve their understanding of the cascade of events that lead to retinal degeneration and vision loss. This active research [...]

Reviewed by Neil R. Miller, MD Baltimore--Ophthalmologists can now use new guidelines on how best to treat optic neuritis based on the results from the Optic Neuritis Treatment Trial (ONTT), [...]

Reviewed by Julia A. Haller, MD Baltimore--Macular edema is the final common pathway for visual loss in many diseases, but so far, available treatments have not been effective in improving [...]

Baltimore--Taking a firm stance against deceptive advertising for LASIK and other ophthalmic procedures, Matthew Daynard, Esq., outlined Federal Trade Commission (FTC) advertising requirements at the Current Concepts in Ophthalmology meeting, [...]

Reviewed by Rajendra S. Apte, MD, PhD Baltimore -- Digital imaging techniques in medicine have been promoted since the 1980s, but recent technological advances have made it far better than [...]

Baltimore -- Legislation signed Oct. 26, 2002 promises to expedite the FDA device review and approval process. Developed in concert with industry, the Medical Device User Fee and Modernization Act [...]

Reviewed by William L. Rich, MD Baltimore -- The American Academy of Ophthalmology (AAO) has embraced a unified strategy with the hope that the Center for Medicare & Medicaid Services [...]

New York City's only case of inhalation anthrax--diagnosed in Manhattan Eye, Ear, & Throat Hospital (MEETH) employee Kathy Nguyen on Oct. 28th--immediately catapulted the hospital into national news as the [...]

Reviewed by Y. Ralph Chu, MD Edina, MN--The Amadeus microkeratome, marketed by Allergan Inc., offers ophthalmologists greater flexibility in performing LASIK, said Y. Ralph Chu, MD. The Amadeus offers the [...]

Reviewed by R. Doyle Stulting, MD, PhD Kauai, HI--The incidence of intraoperative LASIK complications is strongly associated with the number of procedures that an individual surgeon performs, R. Doyle Stulting, [...]

Reviewed by David R. Hardten, MD KAUAI, HI--With more than 1 million LASIK procedures performed annually in the United States, it is now time to 'fine- tune patient education' and [...]

Reviewed by Neal A. Sher, MD KAUAI, HI--To avoid the pitfalls that can interfere with providing trouble-free LASIK care, pay careful attention to personality traits of potential candidates, and select [...]

Reviewed by Karen Joos, MD, and Louise Mawn, MD NASHVILLE, TN--For the first time, a 'Star Wars'-type free-electron laser (the only approved for human trials in the United States) has [...]

Reviewed by Michael J. Young, PhD NEW YORK--Recent animal research demonstrating that stem cells could be isolated from the hippocampus has pushed research on retinal degeneration into a new direction. [...]

Reviewed by J.P. Dailey, MD New biocompatible magnetic fluids could soon be used as internal tamponades for patients with complex retinal detachments. The goal of this research is to develop [...]

Reviewed by Oliver D. Schein, MD New York--With cataract surgery now the most common surgical procedure performed on Medicare beneficiaries and wide national and international variation in anesthesia practices, it [...]

Evidence-based medicine may be the linchpin of the health care quality movement, but leading figures of the movement at a large international meeting held in Toronto earlier this fall questioned [...]

Josefina Bautista Magno broke ground in getting the medical profession to understand the need for pain relief and palliative care for terminally ill patients. She envisioned an environment where dying [...]

Focuses on the use of testosterone for aging men. Gail Sheehy's popularization of `male menopause'; Health problems attributable to declining testosterone.

Reports that after using the Q-switched Ruby and neodymium: Electronics ytttium-aluminum garnet (YAG) (Nd:YAG) lasers for tattoo removal, localized and generalized contact dermatitis can occur. Reasons for reaction; How to managed reactions.

Discusses the need to educate the public on the harmful effects caused by tanning salons. Risks of skin cancer from tanning; Prevailing public attitude; Failure of previous education efforts.